Prediction of glucose intolerance at 24-28 weeks of gestation by glucose and insulin level measurements in the first trimester.

Iran J Nurs Midwifery Res

Nursing and Midwifery Care Research Center, School of Nursing and Midwifery, Isfahan University of Medical Sciences, Isfahan, Iran.

Published: February 2015

Background: Gestational diabetes is the second common disorder in pregnancy period, which is detected in 24-28 weeks of gestational age through screening tests in low-risk women. The women with gestational diabetes are prone to prenatal mortality and development of future diabetes. Therefore, detection of these individuals in the first trimester and conducting preventive interventions is of great importance. This study aimed to define the predictive value of fasting plasma glucose (FPG) and fasting plasma insulin (FPI) test in first trimester concerning the positive result of oral glucose challenge test (OGCT).

Materials And Methods: This is a prospective and observational study conducted on 88 pregnant women in Tehran. After FPG and FPI measurements in these women in the first trimester, a screening test of GCT with 50 g oral glucose was conducted in 24-28 weeks of gestational age. Diagnostic value of FPG and in these two groups of positive and normal GCT results was evaluated through receiver operator characteristic (ROC) curve. P < 0.05 was considered significant.

Results: In this study, 15 subjects (17%) were detected with a positive GCT result. The sub-curve area of ROC diagram for FPG and FPI was calculated to be 0.573and 0.592, respectively, which reveals that FPG and FPI cannot have a proper predictive value for the positive result of GCT. Based on the results, the best cutoff points for FPG and FPI are 79.5 mg/dl and 7.55 μIU/ml, with accuracy of 60-67% and specificity of 45.2-47%.

Conclusions: Only higher fasting glucose levels in early pregnancy, within the normoglycemic range, would predict the development of glucose intolerance with limited sensitivity and specificity.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4325419PMC

Publication Analysis

Top Keywords

fpg fpi
16
24-28 weeks
12
glucose intolerance
8
gestational diabetes
8
weeks gestational
8
gestational age
8
fasting plasma
8
positive result
8
oral glucose
8
glucose
6

Similar Publications

Background: Treatment with different antipsychotics can lead to various metabolic side effects in patients with psychosis, impacting long-term prognosis. This study aimed to compare the changes and clinical efficacy of insulin resistance in patients treated with olanzapine and ziprasidone.

Method: A retrospective analysis was conducted on the clinical data of 80 patients with schizophrenia.

View Article and Find Full Text PDF

Potential Mediating Role of Iron Biomarkers in the Association of Sex With Glucose, Insulin, and Type 2 Diabetes.

J Endocr Soc

May 2024

Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.

Article Synopsis
  • This study investigates how iron markers might influence the relationship between biological sex and the risk of developing type 2 diabetes (T2D).
  • Researchers analyzed health data from a large group of individuals in the Netherlands, measuring various iron-related biomarkers and glucose levels.
  • Results showed that females generally had lower glucose levels and a lower incidence of T2D compared to males, with certain iron biomarkers (like ferritin) partially explaining these differences.
View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates the relationship between mean platelet volume (MPV) and cardiovascular issues, focusing on patients with normal glucose tolerance (NGT), newly diagnosed type 2 diabetes (T2DM), and pre-diabetes.
  • - Researchers enrolled 400 hypertensive patients and used tests like the Oral Glucose Tolerance test (OGTT) and echocardiography to measure factors such as arterial stiffness and myocardial health.
  • - Findings indicate that MPV levels rise significantly in T2DM and pre-diabetes patients and correlate positively with increased arterial stiffness and early heart damage, suggesting MPV could be a new marker for cardiovascular risk.
View Article and Find Full Text PDF

Silymarin Reduced Insulin Resistance in Non-Diabetic Women with Obesity.

Int J Mol Sci

February 2024

Facultad de Química, Universidad Nacional Autónoma de México, Ciudad de México 04510, Mexico.

Silymarin has ameliorated obesity, type 2 diabetes (T2DM), and insulin resistance (IR) in combination with standard therapy, diet, or exercise in recent studies. Obesity and IR are the main risk factors for developing T2DM and other metabolic disorders. Today, there is a need for new strategies to target IR in patients with these metabolic diseases.

View Article and Find Full Text PDF

Introduction: Glycemic markers throughout life are associated with increased risk of midlife cognitive decline, yet it is unclear whether these associations differ by race and sex.

Methods: This study used cross-sectional analysis of prospectively maintained cohort. 1,295 participants in the Bogalusa Heart Study, a biracial epidemiological cohort located in a micropolitan area core setting, provided fasting plasma insulin (FPI) and glucose (FPG) biannually from 1973 to 2016.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!